Drug intelligence / Profile preview

MAMIAI

Development stage
Unknown
Lead developer
Hanmi Pharmaceutical
Modality
Small Molecules, Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

MAMIAI is a well-known Chinese brand primarily offering probiotic products for infants and children. Its flagship product is a combination of live beneficial bacteria, specifically Bacillus subtilis (R-179) and Enterococcus faecium (R-026), along with a blend of multivitamins (Vitamin C, B1, B2, B6, B12, Niacinamide) and trace elements (Calcium, Zinc). It is designed to support digestive health and improve gut flora in babies and young children. The product works by regulating the intestinal environment, promoting the growth of normal intestinal flora, and inhibiting pathogenic bacteria, while also supplementing essential vitamins and minerals. It is indicated for various digestive issues such as diarrhea, constipation, dyspepsia, and intestinal flora imbalance.

Brand names
MAMIAI妈咪爱Mamiai Probiotic PowderMamiai Bear Probiotics
Other names
Combined Bacillus Subtilis and Enterococcus Faecium Granules with Multivitamines, Live枯草杆菌二联活菌颗粒

Beyond the preview

Go deeper on MAMIAI.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAMIAI.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call